StockNews.com Initiates Coverage on Streamline Health Solutions (NASDAQ:STRM)

StockNews.com began coverage on shares of Streamline Health Solutions (NASDAQ:STRM) in a report issued on Thursday morning. The brokerage issued a sell rating on the stock.

Separately, Craig Hallum raised Streamline Health Solutions to a “strong-buy” rating in a research report on Thursday, September 5th.

Streamline Health Solutions Price Performance

Shares of STRM opened at $2.28 on Thursday. Streamline Health Solutions has a 52-week low of $2.03 and a 52-week high of $9.75. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.61 and a current ratio of 0.61. The business’s 50 day moving average price is $0.82 and its two-hundred day moving average price is $0.56. The firm has a market cap of $141.43 million, a PE ratio of -7.13 and a beta of 1.60.

Streamline Health Solutions (NASDAQ:STRM) last issued its quarterly earnings results on Wednesday, September 11th. The company reported ($0.05) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.04) by ($0.01). Streamline Health Solutions had a negative net margin of 92.72% and a negative return on equity of 44.85%. The business had revenue of $4.48 million during the quarter.

About Streamline Health Solutions

Streamline Health Solutions, Inc offers health information technology solutions and associated services for hospitals and health systems in the United States and Canada. The company offers RevID, an automated revenue reconciliation software; eValuator, a coding analysis platform; data comparison engine; coding and clinical documentation improvement (CDI) solutions, including CDI, abstracting, and physician query; and financial management solutions, such as accounts receivable management, denials management, claims processing, spend management, and audit management.